Obamacare sign-ups rise but overall enrollment set to fall | | NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program. |
| |
U.S. appeals court vacates conviction of drug distributor over Botox | | (Reuters) - A U.S. appeals court on Wednesday vacated the conviction of the owner of a wholesale drug distributor accused of selling authentic Botox and other drugs with foreign labels, dealing another setback to the government, which has struggled at times to successfully prosecute similar such cases. |
| |
U.S. study sheds light on how Zika causes nerve disorder | | CHICAGO (Reuters) - A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday. |
| |
Revance will wait to seek backing for Botox-rival | | (Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview. |
| |
| | |